(Q31144246)

English

Improvement of overall survival in stage IV melanoma patients during 2011-2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Improvement of overall survival in stage IV melanoma patients during 2011-2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR). (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

5

0 references

Thomas Kurt Eigentler

6

object named as

Thomas Kurt Eigentler

0 references

author name string

Andrea Forschner

1

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Felizitas Eichner

2

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Teresa Amaral

3

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Ulrike Keim

4

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Thomas Kurt Eigentler

6

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

publication date

22 November 2016

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

143

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

533-540

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Final version of 2009 AJCC melanoma staging and classification

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Combined vemurafenib and cobimetinib in BRAF-mutated melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Ipilimumab in a Phase II trial of melanoma patients with brain metastases

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Effectiveness of carboplatin and paclitaxel as first- and second-line treatment in 61 patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Nivolumab in previously untreated melanoma without BRAF mutation

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Pembrolizumab versus Ipilimumab in Advanced Melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: retrospective analysis of efficacy and safety data from a phase II trial

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Management of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Targeted Therapy for Melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2309-Y

21 January 2018

Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".

1 reference

https://pubmed.ncbi.nlm.nih.gov/27878363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-016-2309-Y

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31144246&oldid=2195105653"